Recruitment strategies and participant motivations in a digital randomized controlled trial for the prevention of anxiety disorders: the prevANS study

• by Cristina García-Huércano, Sonia Conejo-Cerón, Alberto Rodríguez-Morejón, Carmela Martínez-Vispo, Natalia Sánchez-Aguadero, Olaya Tamayo-Morales, Patricia Moreno-Peral

• May 13, 2026

Psilocybin for Cocaine Use: Signal or Noise?

Pilot randomized study suggests possible benefit, but blinding concerns and limited generalizability complicate interpretation

• by Kathryn Wighton

• May 7, 2026

• 6 min

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment

• by Kathryn Wighton

• May 6, 2026

• 5 min

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

• by Kathryn Wighton

• May 5, 2026

• 5 min